Executive Summary: Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy. American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition)


Cite item

Full Text

Abstract

About the authors

Terese T. Horlocker

Mayo Clinic, Rochester

Denise J. Wedel

Mayo Clinic, Rochester

John C. Rowlingson

University of Virginia Health Science Center

Kayser Enneking

University of Florida

References

  1. Enneking F. K., Benzon H. Oral anticoagulants and regional anesthesia: a perspective // Reg. Anesth. Pain Med. 1998; 23: 140-145.
  2. Horlocker T. T., Wedel D. J. Neuraxial block and low-molecular -weight heparin: balancing perioperative analgesia and thromboprophylaxis // Reg. Anesth. Pain Med. 1998; 23: 164-177.
  3. Horlocker T. T., Wedel D. J., Benzon H. et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation) // Reg. Anesth. Pain Med. 2003; 28: 172-197.
  4. Liu S. S., Mulroy M. E. Neuraxial anesthesia and analgesia in the presence of standard heparin // Reg. Anesth. Pain Med. 1998; 23: 157-163.
  5. Rosenquist R. W., Brown D.L. Neuraxial bleeding: fibrinolytics/ thrombolytics // Reg. Anesth. Pain Med. 1998; 23: 152-156.
  6. Urmey W. F., Rowlingson J. Do antiplatelet agents contribute to the development of perioperative spinal hematoma? // Reg. Anesth. Pain Med. 1998; 23: 146-151.

Copyright (c) 2010 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies